The Effect Of Continuous Care Model On The Quality Of Life And Adherence To Treatment In Breast Cancer Patients Undergoing Chemotherapy. Breast, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Before implementing the intervention with therapeutic communication techniques, the researcher will explain the intervention to the patient. This care technique inc
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age above 18 years Not having problems such as mental retardation, mental behavioral disorder and hearing according to the patients medical record Failure to participate in similar training courses Having minimum literacy to read and write and use of a continuing care program Having breast cancer for at least 1 year Female gender Having a mobile phone personally or in the family or having a fixed phone in the place of residence A native of Semnan province Complete consent of the patient and family to refer and follow up a phone number, a purpose of treatment and continuing training and counseling required by the researcher
Exclusion criteria
Exclusion criteria: The occurrence of severe physical complications caused by the disease Death of the patient Metastasis to other parts and organs of the body Unwillingness to continue cooperation Absence of more than two sessions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score that the patient receives from the specific quality of life questionnaire for cancer patients (EORTC QLQ-C30) ranges from 30 to 126. Timepoint: It is before the start of the intervention and one month and three months after the end of the intervention. Method of measurement: The score obtained by the patient from the questionnaire (EORTC QLQ-C30) which is specific for cancer patients and includes 9 subscales and mostly 30 questions in the range of 126-30. This questionnaire includes 5 functional domains, 9 symptom domains and one general domain of quality of life. This questionnaire is based on a four-point Likert scale. Not at all (score 1), a little (score 2), a bit (score 3), very much (score 4). To calculate the score of each subscale, the score of each item related to that subscale is added together. The minimum and maximum score of this questionnaire is 30 and 126. The higher the score obtained from this questionnaire, the higher the quality of life and vice versa.;The score that a person gets from the 8-item treatment adherence questionnaire (MMAS-8) and the range of total scores is between 0 and 8. Timepoint: It is before the start of the intervention and one month and three months after the end of the intervention. Method of measurement: The drug treatment compliance questionnaire has 8 questions and measures drug treatment compliance. MMAS-8 drug treatment compliance questionnaire includes seven two-choice questions (with yes and no answers) and one Likert-type question, and question number 5 is scored in contrast to other questions. The range of total scores is between 0 and 8. The lower the score, the more people will adhere to medication. Scoring: In questions 1 to 7, yes answers are given a score of 1 and no answers are given a zero score. Question 5 is scored in reverse. In question 8, a score of 1, sometimes a score of 0.75, usually a score of 0.5, usually a score of 0.25, and always a score of zero is given for the answer of never. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajad Salehipour
Semnan University of Medical Sciences
Outcome results
None listed